The European Medicines Agency (EMA) said it was investigating a contamination incident in the manufacturing of Moderna COVID-19 vaccines to assess whether there was an impact on EU supply. Japan suspended the use of 1.63 million doses of Moderna vaccine, with the company saying contamination could be due to a manufacturing issue on one of the production lines at its contract manufacturing site in Spain.
Read more on CDE News